PATH is looking for a vendor to provide pharmaceutical products with HCV treatment medication, namely Sofosbuvir 400mg and Daclatasvir 60mg (Daclatasvir dihydrochloride) to support the research study in Vietnam under the HIV Self-Testing Africa (STAR), a Unitaid-funded initiative. Through the HIV Self-Testing Africa consortium, PATH will conduct implementation research to assess different HCVST delivery models in two HIV Self-Testing Africa countries—India and Vietnam—which have high HCV disease burden and diagnostic gaps among KPs and PLHIV.
Quantity and detailed requirements of the products are listed in the attached Request for Quotation (RFQ) [1] .
Deadline for quotation submission is 5:00PM (Hanoi time, GMT+7) on March 30, 2023
For submission of quotation and queries, please email to:
Finance/Administrative Contact: Mr. Tran Minh Dung. Email: [email protected] [2]
Technical/Program Contact: Mr. Do Tuan Kim. Email: [email protected] [3]
Procurement Associate Contact: Ms. Nguyen Thuc Hang. Email: [email protected] [4]